Using Peripheral Blood (PB) Measurable Residual Disease (MRD) Levels to Predict &lt;0.01% Bone Marrow Disease (BM uMRD4): Identification of Effective PB Targets for CLL Treatment Cessation in the Ibrutinib+Venetoclax Arm of the FLAIR Trial

Rawstron, Andy; Webster, Nichola; Dalal, Surita; de Tute, Ruth M; Bell, Sue; Cairns, David Allan; Girvan, Sean; Greatorex, Natasha; Hockaday, Anna; Jackson, Sharon; Phillips, David; Stones, David; Allsup, David; Bloor, Adrian John Clifton; Sarma, Anita; Varghese, Abraham Mullasseril; Munir, Talha; Hillmen, Peter

doi:10.1182/blood-2023-187943

Using Peripheral Blood (PB) Measurable Residual Disease (MRD) Levels to Predict <0.01% Bone Marrow Disease (BM uMRD4): Identification of Effective PB Targets for CLL Treatment Cessation in the Ibrutinib+Venetoclax Arm of the FLAIR Trial

Rawstron, Andy; Webster, Nichola; Dalal, Surita; de Tute, Ruth M; Bell, Sue; Cairns, David Allan; Girvan, Sean; Greatorex, Natasha; Hockaday, Anna; Jackson, Sharon; Phillips, David; Stones, David; Allsup, David; Bloor, Adrian John Clifton; Sarma, Anita; Varghese, Abraham Mullasseril; Munir, Talha; Hillmen, Peter

Authors

Andy Rawstron

Nichola Webster

Surita Dalal

Ruth M de Tute

Sue Bell

David Allan Cairns

Sean Girvan

Natasha Greatorex

Anna Hockaday

Sharon Jackson

David Phillips

David Stones

Dr David Allsup D.J.Allsup@hull.ac.uk
Senior Lecturer in Haematology and Honorary Consultant

Adrian John Clifton Bloor

Anita Sarma

Abraham Mullasseril Varghese

Talha Munir

Peter Hillmen

Citation

Rawstron, A., Webster, N., Dalal, S., de Tute, R. M., Bell, S., Cairns, D. A., …Hillmen, P. (2023). Using Peripheral Blood (PB) Measurable Residual Disease (MRD) Levels to Predict <0.01% Bone Marrow Disease (BM uMRD4): Identification of Effective PB Targets for CLL Treatment Cessation in the Ibrutinib+Venetoclax Arm of the FLAIR Trial. Blood, 142(Supplement 1), 632-632. https://doi.org/10.1182/blood-2023-187943

Journal Article Type	Conference Paper
Conference Name	65th ASH Annual Meeting and Exposition
Conference Location	San Diego, CA
Acceptance Date	Oct 2, 2023
Online Publication Date	Nov 28, 2023
Publication Date	Nov 2, 2023
Deposit Date	Jan 17, 2024
Publicly Available Date	Nov 3, 2024
Journal	Blood
Print ISSN	0006-4971
Electronic ISSN	1528-0020
Publisher	American Society of Hematology
Peer Reviewed	Peer Reviewed
Volume	142
Issue	Supplement 1
Pages	632-632
DOI	https://doi.org/10.1182/blood-2023-187943
Keywords	Cell Biology; Hematology; Immunology; Biochemistry
Public URL	https://hull-repository.worktribe.com/output/4519285